Overview

Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia

Status:
Not yet recruiting
Trial end date:
2023-01-05
Target enrollment:
Participant gender:
Summary
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
Phase:
Phase 3
Details
Lead Sponsor:
Visus Therapeutics
Treatments:
Brimonidine Tartrate
Carbachol